We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quality Compliance Concerns Land DePuy a Warning Letter
Quality Compliance Concerns Land DePuy a Warning Letter
February 3, 2012
The FDA slapped Johnson & Johnson’s DePuy Orthopaedics with a warning letter citing quality system compliance concerns at its Warsaw, Ind., plant, including lack of proper design validation procedures.